Quotient Biodiagnostics LaunchesTwo New Products Including First of its Red Blood Cell Products, ALBAcyte® IgG Sensitized Cells, and ALBAlect® Anti-A1 Lectin

NEWTOWN, PA. (November 1, 2010) - Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to hospitals and blood banks, today announced that it had launched two new products including: ALBAcyte® IgG Sensitized Cells and ALBAlect® Anti-A1 Lectin.

 New  ALBAcyte® IgG Sensitized Cells can cost 40-60% less than primary competitors.

Get Answers Here